Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 31% ± 11% | |
brain | 18 studies | 33% ± 18% | |
peripheral blood | 16 studies | 32% ± 9% | |
eye | 11 studies | 32% ± 12% | |
kidney | 9 studies | 25% ± 8% | |
intestine | 9 studies | 31% ± 14% | |
liver | 6 studies | 39% ± 20% | |
lymph node | 5 studies | 33% ± 8% | |
breast | 5 studies | 27% ± 6% | |
pancreas | 4 studies | 51% ± 18% | |
bone marrow | 4 studies | 30% ± 9% | |
uterus | 4 studies | 40% ± 13% | |
adipose | 4 studies | 26% ± 4% | |
placenta | 3 studies | 32% ± 2% | |
heart | 3 studies | 21% ± 2% | |
prostate | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4214.18 | 1445 / 1445 | 100% | 32.98 | 183 / 183 |
lung | 100% | 4334.81 | 578 / 578 | 100% | 24.72 | 1155 / 1155 |
ovary | 100% | 4970.27 | 180 / 180 | 100% | 22.14 | 430 / 430 |
prostate | 100% | 4336.20 | 245 / 245 | 100% | 23.28 | 502 / 502 |
uterus | 100% | 5174.31 | 170 / 170 | 100% | 24.27 | 459 / 459 |
brain | 100% | 3271.05 | 2640 / 2642 | 100% | 21.69 | 705 / 705 |
breast | 100% | 4882.28 | 459 / 459 | 100% | 30.51 | 1117 / 1118 |
thymus | 100% | 4844.17 | 653 / 653 | 100% | 27.41 | 602 / 605 |
pancreas | 100% | 2151.33 | 328 / 328 | 99% | 19.81 | 177 / 178 |
bladder | 100% | 4652.95 | 21 / 21 | 99% | 20.26 | 499 / 504 |
adrenal gland | 100% | 3822.16 | 258 / 258 | 98% | 17.48 | 226 / 230 |
stomach | 100% | 3347.31 | 359 / 359 | 98% | 23.56 | 281 / 286 |
liver | 100% | 2821.97 | 226 / 226 | 98% | 13.10 | 398 / 406 |
intestine | 100% | 4842.30 | 966 / 966 | 98% | 22.80 | 515 / 527 |
kidney | 100% | 2983.18 | 89 / 89 | 97% | 17.25 | 872 / 901 |
skin | 100% | 4389.56 | 1809 / 1809 | 92% | 18.84 | 432 / 472 |
blood vessel | 100% | 4762.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.06 | 29 / 29 |
muscle | 100% | 3431.04 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4398.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.53 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.16 | 1 / 1 |
adipose | 100% | 4643.49 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 2605.51 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 74% | 2546.84 | 692 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 55% | 6.12 | 44 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0008380 | Biological process | RNA splicing |
GO_0000413 | Biological process | protein peptidyl-prolyl isomerization |
GO_0016363 | Cellular component | nuclear matrix |
GO_0016607 | Cellular component | nuclear speck |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0016018 | Molecular function | cyclosporin A binding |
GO_0005515 | Molecular function | protein binding |
GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | PPIG |
Protein name | Peptidylprolyl isomerase G Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G) Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) peptidylprolyl isomerase (EC 5.2.1.8) |
Synonyms | |
Description | FUNCTION: PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding . May be implicated in the folding, transport, and assembly of proteins. May play an important role in the regulation of pre-mRNA splicing. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . |
Accessions | ENST00000417938.2 Q32LZ0 ENST00000462903.6 [Q13427-2] ENST00000414307.6 [Q13427-2] ENST00000678638.1 A0A7I2V4W3 ENST00000678499.1 [Q13427-1] ENST00000433207 ENST00000676508.1 A0A7I2V629 E9PG73 Q13427 A0A7I2V4F2 A0A7I2V2U3 ENST00000260970.8 [Q13427-1] ENST00000433207.6 [Q13427-1] ENST00000448752.7 [Q13427-1] C9JM79 ENST00000482772.5 ENST00000679107.1 [Q13427-1] ENST00000676756.1 [Q13427-1] Q6P432 ENST00000678721.1 ENST00000409714.7 A0A7I2V5Q5 C9J679 C9JN15 ENST00000414307 Q2NKQ6 ENST00000678088.1 |